• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Total number of clinical trials
  • Oral Mucosal Absorption of ICI176,334-1

Disease
prostate cancer
Drug Name
Casodex
Generic Name
bicalutamide
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
I
Start Date
Jan 18, 1971
Study Name
D6874L00026
Study Id
D6874L00026
ClinicalTrials.gov ID
NCT01415791
Recruiting Status
Closed
Protocol Status
Not Available
Report
Jul 2, 2012
  • D6874L00026.pdf (125 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013